ESSAG试验协议:一项随机对照试验,评估一般医生提供自取样套件的有效性,以达到在常规宫癌查计划中被强调的妇女

Eva Gezels1, Kaatje Van Roy1, Marc Arbyn2

  • 1Department of Public Health and Primary Care, Ghent University, C Heymanslaan 10, 9000 Ghent, Belgium.

PubMed
概括

提供自取样套件 (SSK) 的全科医生可能会增加那些通常不定期参加查的女性的宫癌 (CC) 查参与率. 这一战略旨在提高CC查覆盖率的低于最佳水平.

相关概念视频

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...